Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 11/28/2025LEK: China's Clinical Trial Sector Enters a New Phase of Innovation an...
  • 11/27/2025MC's China Biopharma Tracker: Dealmaking, Approvals, and $451 Million ...
  • 11/21/2025China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...
  • 11/21/2025US Report Flags Risks From China's Expanding Control of Pharma Supply ...
  • 11/20/2025China Biopharma Tracker – October 2025 (PharmaDJ)
  • 11/20/2025China's Innovation-drug BD Boom Slows as Investors Shift Focus to Prod...
  • 11/18/2025China's October Approvals Signal the Next Five Years of Translational ...
  • 11/18/2025China Biopharma Strikes Record USD 19.9 B in Licensing Deals in Octobe...
  • 11/14/2025MNCs Face Diverging Fortunes and Strategic Reset in China
  • 11/14/2025Review of China's Late-Stage Global Innovative Drug Pipeline in 2025
  • 11/13/2025Innovative Antibody Therapeutic Development in China Compared with the...
  • 11/5/2025China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative ...
  • 11/5/2025MNCs Retreat as China Cancels Dozens of Branded Medicines Amid Price C...
  • 11/5/2025Bloomberg: China Has Another Trade Weapon Waiting for America — Pharm...
  • 10/31/2025China's Biotech Deal Boom Tests Ethical Boundaries as Valuations Soar ...
  • 10/29/2025China Pushes Ethical Limits in Global Biotech Race With Gene-Edited An...
  • 10/22/2025Understanding China's Longevity Market: Industry Segments, Trends and ...
  • 10/21/2025ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation
  • 10/17/2025Novo vs. KBP: Fraud or Due Diligence Slipup? (FierceBiotech)
  • 10/13/2025First Drug Patent Term Extension Granted In China (Mondaq)
  • 10/13/2025U.S. Senate Approves Revised China Biotech Competition Bill with Softe...
  • 10/13/2025China's Innovative Drug Sector Secures Over CNY 4.2B in Q3 Financing, ...
  • 9/23/2025Challenges and Opportunities in Oncology Drug Development and Clinical...
  • 9/23/2025China's Edge over U.S. Biotech Was Never Scientific (Washington Post)
  • 9/22/2025China's Role in Global Drug Approvals Expands as Regulatory Timelines ...
  • 9/19/2025PRC Consolidates Pharmaceutical Supply Chain Dominance (TJF)
  • 9/19/2025​​​​​​​China Biopharma at Crossroads: A Mid-2025 Tale of Contra...
  • 9/19/2025Gottlieb Cautions Blanket China Drug Licensing Ban amid Calls for Rigo...
  • 9/19/2025Obesity in China (The Lancet)
  • 9/19/2025China's Biotechs Navigate the Demands of International Trials (Clinica...
  • Page:1/6 Total number of articles:175: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group